Skip to main content

Werewolf Therapeutics, Inc.

HOWL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001785530

In the last 90 days, Werewolf Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 45 institutions reported holding it in 13F filings for Q2 2026, worth $3.91M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Werewolf Therapeutics, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of HOWL: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders7065−5
Shares27.4M22.3M−5.13M (−18.7%)
Value$26.7M$24.3M−$2.36M (−8.8%)

New holders (17)

Institutions that held Werewolf Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to HOWL in Q2 2025
InstitutionSharesValue% of portfolio
Jane Street Group, LLC374,939$408.7K0.00%
Marshall Wace, LLP103,785$113.1K0.00%
Y-Intercept (Hong Kong) Ltd84,421$92.0K0.00%
Qube Research & Technologies Ltd44,261$48.2K0.00%
HRT Financial LP42,480$46.0K0.00%
Jain Global LLC26,983$29.4K0.00%
Quadrature Capital Ltd25,791$28.0K0.00%
Two Sigma Securities, LLC22,409$24.4K0.00%
Point72 Asia (Singapore) Pte. Ltd.20,126$21.9K0.00%
Raymond James Financial Inc13,044$14.2K0.00%
Jump Financial, LLC11,345$12.4K0.00%
Avantax Advisory Services, Inc.10,200$11.1K0.00%
Highline Wealth Partners LLC10,000$10.9K0.00%
Nisa Investment Advisors, LLC1,375$1.50K0.00%
Point72 (DIFC) Ltd403$4390.00%
Essential Partners LLC52$570.00%
Plante Moran Financial Advisors, LLC50$550.00%

Sold out (22)

Institutions that held Werewolf Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.